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TO THE EDITOR
Mast cells are necessary for allergic
reactions, but they are also important in
inflammatory conditions that are wor-
sened by stress (Theoharides and Co-
chrane, 2004). Dermatoses, such as
atopic dermatitis and psoriasis, are
aggravated by stress (Panconesi and
Hautmann, 1996; Katsarou-Katsari
et al., 1999). Acute stress or intradermal
administration of corticotropin-releas-
ing hormone (CRH) can activate skin
mast cells (Theoharides et al., 1998;
Singh et al., 1999) that are located
perivascularly close to nerve endings.
CRH and CRH receptor (CRH-R) mRNA
are expressed in human and rodent skin
(Slominski et al., 1995, 1996), in
association with the hair cycle (Roloff
et al., 1998; Pisarchik and Slominski,
2001). Increased CRH-R1 gene expres-
sion was documented in the affected
skin from patients with chronic urticaria
(Papadopoulou et al., 2005). Moreover,
CRH-R1 is involved in the stress-in-
duced exacerbation of chronic contact
dermatitis in rats (Kaneko et al., 2003).
Mast cells could be unique targets of
CRH and related peptides, contributing
to neurogenic inflammation (Theohar-
ides et al., 2004).
Here, in situ hybridization and im-
munohistochemistry (IHC) were used to
localize CRH-R on mouse skin mast
cells. Mouse skin sections hybridized
with 33P-labeled antisense CRH-R1
riboprobe displayed silver grains in the
outer root sheath of hair follicles (Figure
1a). Clusters of signal were also asso-
ciated with certain perifollicular cells
(Figure 1b) with morphological charac-
teristics of mast cells: fairly large size,
irregular shape, and perivascular loca-
lization. A skin section hybridized with
33P-labeled sense CRH-R1 probe dis-
played no specific labeling (Figure 1c).
To confirm whether mast cells express
CRH-R protein, IHC was performed,
and the sections were subsequently
stained with toluidine blue, a histologi-
cal stain for mast cells. The distribution
and morphology of the perifollicular
cells expressing CRH-R1 mRNA (Figure
1b) determined by in situ hybridization,
was virtually identical to the CRH-R-
like immunoreactivity detected using
IHC (Figure 2a); these perifollicular
cells stained with toluidine blue (Figure
2b). CRH-R-like immunoreactivity (Fig-
ure 2c) was also present on toluidine
blue positive cells found adjacent to
blood vessels, (Figure 2d). The present
results suggest that a small population
of perifollicular and perivascular skin
mast cells express CRH-R. The findings
were confirmed recently with FACS
analysis of a population of disaggre-
gated skin cells double positive for
CRH-R and the mast cell growth factor
receptor c-kit (Donelan et al., 2006).
Previous reports have shown CRH-R1
expression in the outer root sheath, hair
matrix, and dermal papilla of mouse
skin (Slominski et al., 1996, 2001;
Roloff et al., 1998). CRH-R2 expression
in the epidermis, hair follicle, and
sebaceous glands of rodents had been
reported by molecular and immunolo-
gical detection (Slominski et al., 2004).
The expression of CRH-R1 in and
around the hair follicle may help
explain stress-induced hair loss. Expres-
sion of different CRH-R1 isoforms is
hair cycle dependent; whereas CRH-
R1a is absent in telogen, it is present in
anagen (Pisarchik and Slominski,
2001), which may explain differential
responsiveness of mouse skin to CRH
ligands. During the cyclic remodeling
of the hair follicle, the perifollicular
innervation undergoes significant
changes in sensory skin innervation
and in mast cell–nerve contacts (Peters
et al., 2001); perifollicular mast cells
also modulate hair follicle cycling (Paus
et al., 1994). Moreover, the hair follicle
was recently identified as a major
source of skin mast cell progenitors
(Kumamoto et al., 2003).
Murine hair growth in vivo and in
situ is modulated by stress response
mediators that can act as endogenous
mast cell secretagogues (Peters et al.,
2004). Sound-induced psychological
stress was shown to increase the num-
ber of apoptotic cells in the hair follicle
and significantly increase the number of
degranulated mast cells (Arck et al.,
2001); these effects could be mimicked
by injection with the neuropeptide
substance P. In the absence of func-
tional mast cells or the substance P
receptor NK-1R, stress failed to induce
premature hair follicle regression (Arck
et al., 2005). In addition to substance P,
neurotensin (Singh et al., 1999) could
activate skin mast cells and it was
recently shown that the intradermal
effect of CRH on vascular permeability
was dependent on neurotensin (Done-
lan et al., 2006).
Acute stress increases CRH in the
skin of rodents (Lytinas et al., 2003) and
intradermal CRH administration in rats
leads to activation of skin mast cells
and increased vascular permeability
(Theoharides et al., 1998). Both CRH
and its structurally related peptide
urocortin are produced by human skin
cells (Slominski et al., 1998; Slominski
et al., 2000), whereas mice only pro-
duce urocortin (Slominski et al., 2000).
In mice, CRH is delivered to the skin by
nerve endings (Slominski et al., 1996,
1999). CRH administration in humans
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causes peripheral skin vasodilation and
flushing dependent on CRH-R1 and
mast cells (Crompton et al., 2003).
Human mast cells express mRNA and
protein for a number of CRH-R1 iso-
forms and CRH-R2 (Cao et al., 2005),
suggesting there could be autocrine
effects. Human mast cells synthesize
both CRH and urocortin that could be
released in response to immunologic
stimulation (Theoharides and Co-
chrane, 2004). Mast cells can secrete
histamine and tryptase, which can
stimulate proteinase-activated receptors
on sensory neurons, which in turn
enhance the inflammatory response
via the release of additional substance
P (Steinhoff et al., 2000). Mast cells can
also secrete vascular endothelial
growth factor, an isoform of which is
vasodilatory (Grutzkau et al., 1998). In
fact, CRH could stimulate selective
release of vascular endothelial growth
factor (Cao et al., 2005), which is
overexpressed in psoriatic skin and in
delayed hypersensitivity reactions
(Brown et al., 1995); moreover, over-
expression of vascular endothelial
growth factor in mouse skin was shown
to lead to skin inflammation resembling
psoriasis (Xia et al., 2003).
The skin has been shown to have a
peripheral equivalent of the hypothala-
mic–pituitary–adrenal axis (Slominski
and Mihm, 1996; Slominski and Worts-
man, 2000; Ito et al., 2005; Slominski
et al., 2005a, b). A ‘‘brain–skin connec-
tion’’ that involves the hair follicle,
neuropeptides, and mast cells has been
implicated in the pathogenesis of aller-
gic and inflammatory skin diseases
exacerbated by stress (Paus et al.,
2006). The present findings indicate
that a subpopulation of skin mast cells
are involved in these processes.
MATERIALS AND METHODS
In situ Hybridization
Male 25–30 g C57BL/6 mice (Charles River,
NY) were anesthetized with intraperitoneal
administration of ketamine/xylazine (100
and 20 mg/kg each) and killed by decapita-
tion. The fur was removed and the skin was
dissected, immediately frozen in Tissue-Tek
embedding medium and stored at 801C.
Sections (7mm thick) were cut on a cryostat,
were adhered to slides at room temperature,
and were stored at 801C before in situ
hybridization. These experiments were ap-
proved by the Tufts University Intstitutional
Animal Care and Use Committee.
CRH-R1 Probes
A 700 bp fragment of the 50 end of mouse
CRH-R1 coding region was subcloned into
the pcDNA-1 expression vector (Invitrogen,
Eugene, OR) that contains the T7 and
Sp6 RNA polymerase promoter sequence.
T7 and Sp6 RNA polymerase were used
to transcribe the cRNA for CRH-R1
from linearized plasmids. CRH-R1 cRNA
transcripts were labeled using T3 polymer-
ase and [a-33P]UTP (10 mCi/ml) by a stan-
dard transcription reaction (Marchand,
1992, 1994). Isotopically labeled transcripts
were run on an acrylamide denaturing
a b
c
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Figure 1. CRH-R1 mRNA is localized in the hair follicle and cells surrounding the hair follicle. (a)
Photomicrograph of mouse skin section hybridized with 33P-labeled antisense CRH-R1 probe. CRH-R1
autoradiographic signal (silver grains) in hair follicle (d.p. stands for dermal papillae); signal is localized to
the outer root sheath cells (arrow). (b) Photomicrograph of mouse skin section hybridized with 33P-labeled
antisense CRH-R1 probe. CRH-R1 autoradiographic signal is localized in cells (arrow) surrounding the
hair follicle with morphological characteristics of mast cells. (c) Negative control; photomicrograph of
mouse skin section hybridized with 33P-labeled sense CRH-R1 probe. (a–c) Bar¼ 200mm.
a b
c d
Figure 2. Skin mast cells express CRH-R. IHC was performed using a polyclonal rabbit CRH-RI/II
antibody that was detected with a horseradish peroxidase-conjugated secondary antibody. Following
IHC, skin sections were stained with toluidine blue to identify skin mast cells. (a) Low magnification
(10) demonstrating CRH-R-like immunoreactivity localized in the hair follicle (arrowhead) and
perifollicular and perivascular cells (arrow) (*denotes blood vessel lumen). (b) Low magnification ( 10)
of a skin section stained with toluidine blue. Mast cells are localized both around the hair follicles and
blood vessels (arrow). (c) Higher magnification ( 20) of a mouse skin section showing strong CRH-R-like
immunoreactivity on cells (arrow) located adjacent to blood vessels (*denotes blood vessel lumen). (d)
Skin mast cells (arrow) stained with toluidine blue are adjacent to blood vessels (*denotes blood vessel
lumen). Bar: (a, b)¼ 100 mm; (c, d)¼ 50 mm.
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gel to confirm the correct size of the
transcripts.
Hybridization procedure. Tissue sections
were thawed and fixed in 4% paraformal-
dehyde for 15 minutes at room temperature.
After fixation, skin sections from the same
experiment were hybridized together for
single-labeled autoradiographic in situ hy-
bridization as described previously (Cain
et al., 2003).
IHC for CRH-R
IHC was performed on mouse skin sections
using a CRH-RI/II rabbit polyclonal antibody
(Santa Cruz Biotechnology, Inc., Santa Cruz,
CA) together with the DAKO EnVi-
sionþ System-HRP (DAB) (DakoCytoma-
tion, Carpinteria, CA). Cryostat sections
(7mm) were prepared from mouse skin and
fixed with Bouin’s fixative for 5 minutes and
incubated with endogenous peroxidase
blocking reagent for an additional 5 min-
utes. The sections were incubated with
primary antibody (1:75–1:200 dilution) over-
night at 41C. The following day, the sections
were incubated in goat anti-rabbit Ig con-
jugated to horseradish peroxidase for
45 minutes followed by addition of the
substrate chromogen DAB for 10 minutes.
The sections were rinsed in Tris-buffered
saline for 5 minutes between incubations.
Negative controls were performed by the
omission of the primary antibody or its
substitution by a naive isotypic antibody. A
blocking/neutralizing peptide was not avail-
able from Santa Cruz because the CRH-R
antibody used was raised against a recom-
binant peptide and not a peptide antigen.
The presence of brown-colored end product
at the site of the target antigen indicated
positive CRH-RI/II staining. The slides were
then stained with toluidine blue to label the
mast cells.
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